Skip to main content Accessibility Statement

News

December 7, 2017
Tactile Medical to Participate in the Guggenheim Securities 5th Annual Boston Healthcare Conference
MINNEAPOLIS , Dec. 07, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the Guggenheim
Read more
December 7, 2017
Tactile Medical Announces New Clinical Publication Assessing the Use of Flexitouch for the Treatment of Head & Neck Lymphedema
MINNEAPOLIS , Dec. 07, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the publication of a functional use study in the
Read more
November 16, 2017
Tactile Medical to Participate in the 29th Annual Piper Jaffray Healthcare Conference
MINNEAPOLIS , Nov. 16, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the 29th Annual
Read more
November 7, 2017
Tactile Systems Technology, Inc. Reports Third Quarter 2017 Financial Results; Updates 2017 Outlook
Q3 Revenue Increase of 25% Year-over-Year; Revenue Up 33% Year-to-Date MINNEAPOLIS , Nov. 07, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at
Read more
October 11, 2017
Tactile Medical to Release Third Quarter 2017 Financial Results on November 7, 2017
MINNEAPOLIS , Oct. 11, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that third quarter 2017 financial results will be
Read more
September 20, 2017
Tactile Medical Announces Appointment of Raymond Huggenberger to Board of Directors
MINNEAPOLIS , Sept. 20, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the appointment of Raymond O.
Read more
September 13, 2017
Tactile Medical Announces Pricing of Secondary Offering of Common Stock
MINNEAPOLIS , Sept. 13, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology , Inc. (“ Tactile Medical” or the “Company”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the pricing of a previously
Read more
September 12, 2017
Tactile Medical Announces Secondary Offering of Common Stock
MINNEAPOLIS , Sept. 12, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology , Inc. (“ Tactile Medical” or the “Company”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that certain of its stockholders
Read more
August 7, 2017
Tactile Systems Technology, Inc. Reports Second Quarter 2017 Financial Results; Updates 2017 Outlook
Q2 Revenue Increase of 33% Year-over-Year; Revenue Up 38% Year-to-Date MINNEAPOLIS , Aug. 07, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at
Read more
August 1, 2017
Tactile Medical Announces Appointment of Cheryl Pegus to Board of Directors
MINNEAPOLIS , Aug. 01, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the appointment of Cheryl Pegus , MD, MPH, to the
Read more
Displaying 1 - 10 of 23